Biologic therapies demonstrate potential for COPD management, indicating need for precision medicine strategies.
Biologic therapies offer promise for selected COPD phenotypes; however, their long-term impact will depend on precision medicine, optimized airway-targeted delivery, and integration with established inhaled treatments to achieve meaningful disease modification.
No takes yet. Share an insight, caveat, or question.
Afreen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: